Predictive value of immediate early response 5 like (IER5L) in the prognosis and immune checkpoint blockade therapy of non-small cell lung cancer patients
Article in Pathology - Research and Practice (March 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
IER5L is a Prognostic Biomarker in Pan-Cancer Analysis and Correlates with Immune Infiltration and Immune Molecules in Non-Small Cell Lung Cancer
Article in International Journal of General Medicine (December 2023)
Prognostic value of SLC4A4 and its correlation with the microsatellite instability in colorectal cancer
Article in Frontiers in Oncology (April 2023)